eli lilly news - Search News

Eli Lilly’s weight-loss and diabetes drugs are no longer in shortage, says FDA

The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage signaling that the company has succeeded in expanding manufacturing.

Barron's on MSN · 2h

Eli Lilly’s Weight-Loss Drugs No Longer In Shortage. It’s Bad News for These Stocks.

Eli Lilly’s blockbuster obesity and diabetes drugs Zepbound and Mounjaro are no longer in shortage, according to the Food and Drug Administration.It’s a sign that pharmaceutical firm Lilly is making strides to improve the supply issues that have plagued the sector.

Yahoo · 54m

Inside Eli Lilly's fight against counterfeit drugs

"GMA" shares an exclusive look inside the lab of the maker of such drugs as Mounjaro and Zepbound to show what it's doing to warn users about the dangers of counterfeit drugs.

Eli Lilly investing $4.5 billion more into LEAP district

The Indianapolis Star · 4h

Eli Lilly plans $4.5 billion facility in LEAP District, bringing investment to $13 billion

The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing under one roof.

WFYI · 3h

Eli Lilly announces additional $4.5 billion investment into central Indiana LEAP District

Eli Lilly announced Wednesday it will invest another $4.5 billion into a new facility at the states controversial LEAP District in central Indiana.

wrtv · 17h

Eli Lilly investing $4.5 billion more into the LEAP district; residents question IEDC's transparency

The company’s first two investments in the district were for a manufacturing site. The new site will focus on research, but some residents feel the IEDC has not been transparent about the project.

Eli Lilly & Co (LLY) Gets a Buy from Truist Financial

In a report released today, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on Eli Lilly & Co (LLY – Research ...

Eli Lilly, Moderna and more: The 5 highest paid healthcare CEOs

Health care stocks underperformed the broader market in 2023, with many companies falling short of their profit targets, and ...

Pharmaceutical Technology7h

Eli Lilly to invest $4.5bn for drug manufacturing and trial medicine production

Eli Lilly has announced a $4.5bn investment to establish the Lilly Medicine Foundry for drug production and manufacturing ...

22h

Lilly to invest $4.5 bln on new facility to scale-up pipeline drug production

U.S. drugmaker Eli Lilly said on Wednesday it will invest $4.5 billion to create a new center for advanced manufacturing and ...

Eli Lilly Plans $4.5 Billion Research Hub

Drugmaker Eli Lilly said it will spend $4.5 billion to build a new manufacturing research hub in Indiana, where it will develop new methods of producing complicated types of medicines. The new investm ...

19h

Lilly investing $4.5 billion for ‘first of its kind’ medicine foundry in Lebanon

Eli Lilly and Company will invest an additional $4.5 billion in Boone County to create a new center for advanced ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics